Coronavírus Página 11

NEJM - Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

The New England Journal of MedicineNVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike glycoproteins and Matrix-M1 adjuvant.

AMP - SARS-CoV-2 Pandemic: Should Children Wear Masks?

Acta Médica PortuguesaDuring the current SARS-CoV-2 pandemic, the World Health Organization has advised the use of masks, not only in healthcare facilities, but also in particular settings in the community where maintaining physical distance may...

NEJM - Humoral Immune Response to SARS-CoV-2 in Iceland

The New England Journal of MedicineOf the 1797 persons who had recovered from SARS-CoV-2 infection, 1107 of the 1215 who were tested (91.1%) were seropositive; antiviral antibody titers assayed by two pan-Ig assays increased during 2 months after...

WHO - Corticosteroids for COVID-19

World Health OrganizationThis guidance was developed in collaboration with the non-profit Magic Evidence Ecosystem Foundation (MAGIC), which provided methodologic support to develop and disseminate living guidance for COVID-19 drug treatments. We...

AMP - Coronavírus e Lei de Saúde Mental: Novos Desafios, Problemas Antigos

Acta Médica PortuguesaA pandemia COVID-19 poderá ter um impacto significativo na saúde mental da população em geral e, em particular, nas pessoas com doença mental grave. O medo de contrair a infeção, as alterações na rotina diária e a...

NEJM - Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2

The New England Journal of MedicineRapid and accurate diagnostic tests are essential for controlling the ongoing Covid-19 pandemic. Although the current standard involves testing of nasopharyngeal swab specimens by quantitative...

BMJ - Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

The British Medical JournalTo characterise the clinical features of children and young people admitted to hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the UK and explore factors...

BMJ - Two metres or one: what is the evidence for physical distancing in covid-19?

British Medical JournalPhysical distancing is an important part of measures to control covid-19, but exactly how far away and for how long contact is safe in different contexts is unclear. Rules that stipulate a single specific physical distance...

DGS - COVID-19: Desporto e Competições Desportivas

Direção-Geral da Saúde - Orientação

Para infraestruturas desportivas e outros espaços onde decorra prática e competição de desporto federado; federações desportivas com utilidade pública desportiva.

WHO - Advice on the use of masks for children in the community in the context of COVID-19

World Health OrganizationThis document provides guidance to decision makers, public and child health professionals to inform policy on the use of masks for children in the context of the COVID-19 pandemic. It does not address the use of masks for...

JAMA - Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women

JAMA NETWORKConcern has been raised that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be transmitted to infants by breastfeeding. A number of organizations advise that women infected with SARS-CoV-2 may choose to breastfeed...

JAMA - Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial

JAMA NETWORK

Does remdesivir provide a benefit on clinical status for patients hospitalized with moderate coronavirus disease 2019 (COVID-19) pneumonia?

ECDC - Population-wide testing of SARS-CoV-2: country experiences and potential approaches in the EU/EEA and the United Kingdom

European Centre for Disease Prevention and ControlDifferent population-wide testing approaches have already been used in various countries, including household testing, individual testing and the testing of incoming travellers, irrespective of...

JAMA - Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials